Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > First Tranche
View:
Post by Eoganacht on Jul 14, 2024 1:16am

First Tranche

Looks like 18 investors in the first tranche. The second tranche should be much bigger but should comprise only 1 or 2 investors.

  Unique Purchasers Total $Can
Ontario 10 $524,760
USA 4 $80,400
Manitoba 1 $44,000
Alberta 2 $73,040
BC 1 $52,800
Total 18 $775,000

Form 45-106F1 Report of Exempt Distribution
Comment by Oilminerdeluxe on Jul 14, 2024 2:26am
Hope you are right. Would be nice to be cashed up. How long until we hear anything from the second tranche? 
Comment by Legit62 on Jul 14, 2024 6:38am
a single  investor throwing $52,800 at this now looks pretty good, hopefully we get a couple big time investors throwing millions in second tranche
Comment by StevenBirch on Jul 14, 2024 9:59am
Thanks Eog. Should we expect some news to accompany that investment? Could it hopefully happen before Aug 20? The $10M figure does seem odd if there wasn't some sort of interest shown?
Comment by chry200030 on Jul 14, 2024 12:08pm
Lots of money to be made if they get those August 2024 warrants in the money. I'd be all over that if I was in TLT management.
Comment by Oilminerdeluxe on Jul 14, 2024 12:12pm
How are we doing  with new patient updates, when it comes to 360 and 450 days? Anyone in the know if there are any coming up soon?
Comment by Infinity on Jul 15, 2024 11:25am
Great question Oilminer.  Love to know the answers.   I think we managed to go from 63 patients to 67 over a period of 1 year.  Meanwhile CG Oncology got their clinical tests done in multiple countries including South Korea, Taiwan, Canada and Australia and submitted their data to FDA and obtained BTD for the same NMIBC this year. Our direct competition in ACT.  Check out ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250